FDA Expands Approval of Belzutifan for Treatment of pheochromocytoma or paraganglioma Dr. Kamal Kant Kohli16 May 2025 7:45 AM ISTThe US food and Drug Administration (FDA) has expanded the approval of Belzutifan (Welireg) to treat specific types of pheochromocytoma or...
Merck scores USFDA OK for Welireg for 12 years and older with pheochromocytoma or paraganglioma Ruchika Sharma15 May 2025 11:45 AM ISTRahway: Merck, known as MSD outside of the United States and Canada, has received the approval from the U.S. Food and Drug Administration...
Merck Welireg receives European Commission nod for two indications Ruchika Sharma19 Feb 2025 10:30 AM ISTRahway: Merck, known as MSD outside of the United States and Canada, has received conditional approval from the European Commission (EC) for...
Merck WELIREG gets USFDA priority review for Advanced Pheochromocytoma and Paraganglioma Ruchika Sharma28 Jan 2025 11:15 AM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced the U.S. Food and Drug Administration (FDA) has accepted for...
Pivotal study supports belzutifan approval for patients with advanced kidney cancer Dr Kartikeya Kohli25 Aug 2024 8:00 PM ISTBelzutifan is a hypoxia-inducible factor 2 Alpha inhibitor that has showed clinical activity in clear-cell renal-cell carcinoma in early-phase...
Merck Welireg get USFDA priority review for certain previously treated patients with Advanced Renal Cell Carcinoma Ruchika Sharma21 Sept 2023 2:48 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced the U.S. Food and Drug Administration (FDA) has accepted and...
Belzutifan induced strong responses in patients with VHL disease-associated kidney cancer: NEJM Hina Zahid26 Nov 2021 9:00 AM ISTResearchers at The University of Texas MD Anderson Cancer Center have found in a Phase II trial that treatment with belzutifan achieved strong...
Merck HIF-2α Inhibitor Welireg gets USFDA approval to treat tumors Ruchika Sharma16 Aug 2021 10:00 AM ISTKenilworth: Merck, known as MSD outside the United States and Canada, has recently announced that the U.S. Food and Drug Administration (FDA) has...
